Navigation Links
Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
Date:3/27/2008

d therapies.

TRU-015 for RA

In addition to SBI-087, Trubion also announced today the protocol details and design of the next Phase 2b study of TRU-015 for patients with RA that Trubion believes could be supportive of a registration package. The randomized, parallel, double-blind, placebo-controlled, dose regimen-finding study will evaluate the safety and efficacy of two dosing regimens administered to approximately 216 patients with active seropositive RA on a background of methotrexate. The primary outcome measurement for the TRU-015 Phase 2b study will include the American College of Rheumatology (ACR) 50 response measured at 24 weeks. Secondary outcome measurements will be ACR 20 and 70 and DAS-28 responses. This study is currently preparing for participant recruitment.

"SBI-087 strengthens our product pipeline and leverages the combined clinical experience of our strategic collaboration with Wyeth," added Dr. Thompson. "We believe that SBI-087 and TRU-015 together will play an important role in improving patient care and helping us establish category leadership in autoimmune and inflammatory diseases."

TRU-015 and SBI-087 for SLE

Wyeth intends to pursue clinical evaluation of SBI-087 in Systemic Lupus Erythematosus (SLE) and an investigational new drug filing is expected by the end of the year. As a result, Wyeth no longer intends to evaluate TRU-015 in a planned Phase 1 study originally designed to determine how the body absorbs and chemically changes a single infusion of TRU-015 in subjects with kidney disease caused by lupus. No patients were enrolled in the planned TRU-015 Phase 1 study.

TRU-015 for NHL

Trubion also announced today that Wyeth, in reviewing the competitive landscape for CD20-directed therapies, has determined not to pursue such therapies for oncology indications and, as a result, has discontinued clinical development of TRU-015 for non-Hodgkin's lymphoma.

In addition to TRU-015 and SBI-0
'/>"/>

SOURCE Trubion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Trubion Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkins Lymphoma
2. Trubion Pharmaceuticals Announces Presentation of Positive Data From Phase IIb and Re-treatment Studies With TRU-015 in Patients With Rheumatoid Arthritis
3. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
4. Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
5. Metabolex Initiates Phase 1 Trial of MBX-2982
6. Phosphagenics Initiates its Phase 2 Clinical Trial in Type 1 Diabetes
7. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
8. Ception Therapeutics Initiates Phase II/III Clinical Trial for Its Lead Product Reslizumab in Eosinophilic Esophagitis (EE) in Children
9. Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA)
10. Phosphagenics Initiates U.S. Clinical Trials for Its Topical Retinoic Acid
11. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Nov. 26, 2014  CARsgen, a leader in the ... to treat a variety of cancers, today announced the ... a China -based healthcare private equity ... focused on the development of new therapeutics for liver, ... Cancer Institute and Shanghai Renji Hospital, the company plans ...
(Date:11/26/2014)... N.C. , Nov. 25, 2014  At the ... Antonio this October, KaVo Kerr Group was ... Technology Expo, offering attendees the opportunity to see and ... well-respected key opinion leaders deliver lectures on the latest ... Group products include the new DEXIS CariVu Caries Detection ...
(Date:11/26/2014)... 25, 2014   Heska Corporation (NASDAQ: ... a provider of advanced veterinary diagnostic and other specialty ... Executive Chair, will attend The Benchmark Company, LLC,s Micro Cap ... will be held at The Palmer House Hilton, 17 E. ... a.m. to 2:30 p.m. Please email hska@haydenir.com or ...
Breaking Medicine Technology:CARsgen Completes Series A Financing 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3Heska to Attend Benchmark Micro Cap Discovery Conference 2
... /PRNewswire-Asia-FirstCall/ -- China Botanic Pharmaceutical Inc. (AMEX: ... a developer, manufacturer and distributor of botanical products, ... today announced that its wholly owned subsidiary, Harbin ... approval to produce water-based mixtures. The ...
... 12, 2011 Reportlinker.com announces that a new market ... Europe Neurology Devices Market Outlook to 2017 ... Neurology Devices Market Outlook to 2017 ... Devices Market Outlook to 2017" provides key market data ...
Cached Medicine Technology:China Botanic Pharmaceutical Approved to Produce Water-Based Mixtures 2China Botanic Pharmaceutical Approved to Produce Water-Based Mixtures 3Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 2Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 3Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 4Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 5Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 6Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 7Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 8Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 9Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 10Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 11Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 12Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 13Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 14Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 15Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 16Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 17
(Date:11/27/2014)... (PRWEB) November 27, 2014 Blood-borne pathogens ... many medical precautions and procedures in place to counter ... and disposal of things tainted with menstrual blood are ... design a simpler, more sanitary way to handle tampons ... an inventor from Sonora, Calif. , He then created ...
(Date:11/27/2014)... Dotinga HealthDay Reporter , WEDNESDAY, ... pre-wired to acquire a second language, new research suggests. But ... likely gain a brain boost, the small study finds. ... said study co-author Ping Li, co-director of the Center for ... even more interesting, Li said, that "the brain networks of ...
(Date:11/27/2014)... PITTSBURGH, PA (PRWEB) November 27, 2014 In ... an inventor from Sharpes, Fla., designed an easy way to ... lowering it/them. , He then created a prototype of the ... lift or lower a toilet seat and/or lid in a ... which prevents the spread of germs. Overall, it promotes good ...
(Date:11/27/2014)... November 27, 2014 Tylenol lawsuits ( ... allegedly injured by the medication are continuing to move ... is looking ahead to a status conference in December, ... Scheduling Order issued earlier this year, a conference in ... at 10:00 a.m. Items likely to be discussed at ...
(Date:11/27/2014)... DC (PRWEB) November 27, 2014 “LAB.C” was ... which features the latest and coolest technology products available to ... conducted the product review and shared with viewers ... for iOS and Android devices. , Consumers love portability and ... Their Cable Case for the iPhone5 and 5S has ...
Breaking Medicine News(10 mins):Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 3Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2
... be more effective than a "fat" tax for deterring overweight ... study has found. A survey of 364 shoppers in random ... people from reaching for junk food, shoppersincluding those with the ... high fat content and included a note that the item ...
... D.C. It is important that the United States begin to ... APS believes that as a nation we need to be smart ... a clear understanding of what it means for America,s future jeopardizes ... For more than half a century, science and technology have been ...
... (HealthDay News) -- A lack of leptin contributes to the ... of body fat, but treatment with a synthetic form of ... a new study indicates. Extremely low levels of body ... as runners and dancers, and in those with eating disorders. ...
... April 8, 2011 Increased levels of a protein ... a major cardiovascular event in high-risk patients, according to a ... Measuring the amount of the protein, known as plasma renin ... tool to assess a patient,s risk and help prevent a ...
... HealthDay Reporter , THURSDAY, April 7 (HealthDay ... stroke appears to promote arm strength and function, Canadian ... approaches -- including the use of virtual reality [gaming] ... social participation," said lead researcher Dr. Gustavo Saposnik, director ...
... 2011A growing body of research suggests that caffeine disrupts ... poor control of type 2 diabetes, a major public ... of Journal of Caffeine Research : The International ... from Mary Ann Liebert, Inc. publishers, examines the latest ...
Cached Medicine News:Health News:Warning labels better than a fat tax, University of Alberta study shows 2Health News:US House budget plans would jeopardize scientific research facilities 2Health News:Hormone Linked to Absence of Periods in Women With Low Body Fat 2Health News: Video Games Might Aid in Stroke Rehab 2Health News: Video Games Might Aid in Stroke Rehab 3Health News:Caffeine and diabetes -- helpful or harmful? 2
5.5 pointed curved blade. Octagonal handle....
0.5 mm wide x 1.5 mm long. Angled 20 degrees. Octagonal handle....
2 mm wide curved tip. Round handle....
8 mm downcutting Royce blade. Angled shaft. 60 mm from angle to tip....
Medicine Products: